Back to Search
ANDREW WIZNIA, M.D.
M.D.
Pediatric Allergy/Immunology Physician
NPI: 1710054861Individual
Specialties, Licenses & Credentials
Pediatric Allergy/Immunology PhysicianPrimary
Pediatrics — Pediatric Allergy/Immunology
Code: 2080P0201X
150295(NY)
Research & Publications (20)
Safety and efficacy of enfuvirtide for 48 weeks as part of an optimized antiretroviral regimen in pediatric human immunodeficiency virus 1-infected patients.
PMID 17721374·Pediatr Infect Dis J·2007
8-other
Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study Team.
PMID 10954886·AIDS Res Hum Retroviruses·2000
3-trial
Sexual and drug use behavior in perinatally HIV-infected youth: mental health and family influences.
PMID 19564801·J Am Acad Child Adolesc Psychiatry·2009
4-observational
Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in human immunodeficiency virus-infected pediatric patients.
PMID 19106779·Pediatr Infect Dis J·2009
3-trial
Association between skin testing in the pediatric emergency department and adherence to follow-up in children with asthma.
PMID 19205283·Ann Allergy Asthma Immunol·2009
8-other
Rates and types of psychiatric disorders in perinatally human immunodeficiency virus-infected youth and seroreverters.
PMID 19298479·J Child Psychol Psychiatry·2009
8-other
Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjects.
PMID 18332076·Pediatrics·2008
3-trial
Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.
PMID 17709553·J Immunol·2007
4-observational
CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children.
PMID 18090046·AIDS·2007
8-other
Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338).
PMID 17280617·AIDS Res Ther·2007
8-other
Cytomegalovirus-specific cell-mediated immunity in HIV-infected children on HAART.
PMID 16545015·AIDS Res Hum Retroviruses·2006
4-observational
A behavioral and cognitive profile of clinically stable HIV-infected children.
PMID 16510656·Pediatrics·2006
8-other
Partial treatment interruption of protease inhibitor-based highly active antiretroviral therapy regimens in HIV-infected children.
PMID 16540930·J Acquir Immune Defic Syndr·2006
8-other
Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents: pediatric AIDS clinical trials group protocol 403.
PMID 16220085·Pediatr Infect Dis J·2005
3-trial
Switch from ritonavir to indinavir in combination therapy for HIV-1-infected children.
PMID 15791520·Clin Infect Dis·2005
4-observational
Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
PMID 15818296·Pediatr Infect Dis J·2005
3-trial
Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection.
PMID 15995958·J Infect Dis·2005
3-trial
Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection.
PMID 16159645·J Allergy Clin Immunol·2005
3-trial
Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients.
PMID 16184026·AIDS·2005
8-other
Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1.
PMID 16235176·J Infect Dis·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1400 PELHAM PKWY S, JACP-5C-15
BRONX, NY 10461 - Phone
- (718) 918-4664
Quick Facts
- NPI
- 1710054861
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile